Background
==========

Cerebral ischemia is among the most common causes of hospitalization, morbidity and mortality in western civilizations. Stroke databases suggest that despite intensive evaluation, approximately 40% of all patients suffering ischemic strokes have no clearly identifiable cause and 15--20% of the ischemic events occur in younger patients (\<55 years). In the literature, however, there is no consensus on the percentage of ischemic strokes caused by cardioembolic events \[[@B1]\].

Interatrial communications (ASD, PFO with and without atrial septal aneurysms \[ASA\]) can lead to paradoxical stroke and increase the risk for recurrent thrombembolic cerebral events. \[[@B2]-[@B4]\].

In an autopsy study, the overall prevalence of a PFO was 27.3%. \[[@B5]\] A meta-analysis has shown that a PFO is more common in patients younger than \< 55 years with suspected cryptogenic stroke than in healthy controls \[[@B6]\]. Hence, a PFO is considered as a risk factor for ischemic cerebral events in younger patients. In older patients (i.e. \> 55 years), the association between strokes and prevalence of a PFO is much weaker \[[@B7]\].

In clinical practice, it is not easy to verify paradoxical embolism. In current guidelines, there is no consensus on the clinical relevance of a PFO in cryptogenic stroke and on the indication for the closure of a PFO after a stroke \[[@B8]\].

The aim of this study was to determine the prevalence of echocardiographic findings by TEE in a large number of patients with cryptogenic cerebral ischemia with a focus on pre-defined subgroups (age, sex, stroke vs. TIA).

Methods
=======

In this single center retrospective study, 702 consecutive patients with acute cerebral ischemia were examined by TEE (1996--2001). All patients underwent neurological clinical examination, electroencephalogram, cCT or cMRT, and laboratory tests. All patients had a 12-lead-ECG, Holter-ECG, extracranial color-coded sonography, transthoracic echocardiography with no explanations for cerebral ischemia.

Exclusion criteria were: hemodynamically relevant stenoses of the intra- and extracranial arteries, cerebral hemorrhage, atrial fibrillation, migraine, epilepsy, intracranial tumors, acute myocardial infarction in the previous four weeks, previously diagnosed chronic heart failure and left ventricular aneurysms and less than 18 years of age.

Ischemic stroke was defined as a cerebrovascular event with symptoms lasting longer than 24 hours. Diagnosis of ischemic stroke or TIA was confirmed by a study neurologist based on clinical syndrome and results of diagnostic tests, including CT/MRI scans.

Transesophageal echocardiography was performed with a multiplane probe (5--7 MHz) on a Vivid 5 (TEE probe MPTE 5MHz 6A, GE Vingmed, Horton, Norway) and a HP Sonos 5500 (TEE probe HP 21369A; Hewlett-Packard, Paolo Alto, California, USA).

Before transesophageal echocardiography, intraoral xylocaine spray and intravenous midazolam were administered according to the requirements of the patient. The heart rhythm was monitored by ECG during the examination.

Each TEE examination included the standard views and measurement of blood velocities in the left atrial appendage, intravenous administration of contrast agent and Valsalva manoeuvre to exclude interatrial communications (according to \[[@B9]\]).

The images were stored digitally and analyzed off-line by EchoPac PC Dimension (GE Vingmed, Horton Norway) and additionally on video. Echovist 300 was used as contrast medium (Galactose; Schering, Berlin, Germany). Echovist is approved for the diagnosis of intra-atrial communications.

Written consent was obtained from each patient for the TEE, and the ethics committee of the Charité University Hospital approved the protocol.

Statistics
----------

Statistics were calculated by Statgraphics plus (Version 6, Herndon, Virginia USA). Results are expressed as mean (± standard deviation). Comparisons of parametric variables between the responders and the non-responders were calculated by paired Student\'s t-test. The comparison of echocardiographic parameters between groups was calculated by unpaired Whitney-Mann test. Dichotomized data were analyzed by the Chi^2^-test. The level of significance was p ≤ 0.05.

Results
=======

702 consecutive patients were included. 380 (54.1%) were male, 322 (45.9%) female. 383 (54.6%) of the patients had an IS and 319 (45.4%) had a TIA. 411 patients were younger than 55 years (58.5%) and 291 patients were older than 55 years (41.5%).

The stroke subgroup was significantly older and had more frequently pathological TEE findings than the patients suffering from a TIA. (Table [1](#T1){ref-type="table"}).

###### 

Patient characteristics (median, ± SD, n \[%\])

                                               **All (n = 702)**   **Ischemic stroke (n = 383, 54.6%)**   **TIA (n = 319, 45.4%))**   **p**
  -------------------------------------------- ------------------- -------------------------------------- --------------------------- -------------
  **Age**                                      57.1 (± 15.7)       61.5 (± 12.3)                          51.3 (± 16.2)               **\<0.001**
                                                                                                                                      
  **Male Sex (%)**                             380 (54.1%)         222 (57.9%)                            158 (49.5%)                 **0.043**
                                                                                                                                      
  **Diabetes mellitus**                        13.0%               21.2%                                  7.0%                        0.17
                                                                                                                                      
  **Arterial hypertension**                    39.5%               59.4%                                  25.6%                       0.09
                                                                                                                                      
  **Hyperlipidemia**                           35.5%               50.0%                                  25.6%                       0.07
                                                                                                                                      
  **Smoker**                                   26.0%               27.6%                                  25.6%                       0.82
                                                                                                                                      
  **Coronary artery disease**                  14.3%               21.2%                                  9.3%                        0.31
                                                                                                                                      
  **Any pathological echo finding**            369 (52.6%)         225 (58.7%)                            144 (45.1%)                 **0.02**
                                                                                                                                      
  **Number of pathological findings if any**   2.24                2.43                                   1.92                        **0.003**

The prevalence of abnormal echocardiographic findings is listed in (Table [2](#T2){ref-type="table"}). Neither the presence of a PFO (p = 0.053), nor of an ASD (p = 0.65) or an atrial septal aneurysm (p = 0.21) was significantly different in the IS and TIA groups. However, findings attributable to atherosclerosis (valvular abnormalities including mitral valve calcification, aortic calcification, aortic valve sclerosis, aortic plaque) were significantly more frequent in the ischemic stroke group (Table [3](#T3){ref-type="table"}).

###### 

Echocardiographic findings in all patients.

  **Finding**                                       **n**   **%**
  ------------------------------------------------- ------- --------
  *Any echocardiographic finding*                   *369*   *52.6*
                                                            
                                                            
                                                            
  Patent Foramen ovale (PFO)                        152     21.7
                                                            
  Valvular abnormalities                            111     15.8
                                                            
  Aortic plaques                                    102     14.5
                                                            
  Aortic valve sclerosis                            66      9.4
                                                            
  Atrial septal aneurysm                            51      7.3
                                                            
  regional myocardial dyskinesia in \> 2 segments   50      7.1
                                                            
  Left atrial dilatation                            47      6.7
                                                            
  Atrial septal defect                              28      4.0
                                                            
  Spontaneous echo contrast (SEC)                   18      2.6
                                                            
  Mitral valve prolapse                             15      2.1
                                                            
  Valvular vegetations                              14      2.0
                                                            
  Aortic valve strands                              14      2.0
                                                            
  Intracardial thrombi                              13      1.9
                                                            
  mitral valve annulus calcification                10      1.4
                                                            
  Chiari networkt                                   6       0.9
                                                            
  Aortic valve stenosis                             5       0.7
                                                            
  Mitral valve strands                              5       0.7
                                                            
  Aortic thrombi                                    4       0.6
                                                            
  Aortic aneurysm                                   3       0.4
                                                            
  Prosthetic valve                                  3       0.43
                                                            
  Left ventricular dilatation                       3       0.43
                                                            
  Intracardiac tumor                                1       0.14
                                                            
  Mitral valve stenosis                             1       0.14

###### 

The 10 most frequent findings in the stroke and TIA subgroups

  **Rank**   **Ischemic stroke (n = 383)**                                **TIA (n = 319)**                                            **P (Chi2 Pearson)**
  ---------- ------------------------------------------------------------ ------------------------------------------------------------ ----------------------
  1          PFO (94; 24.5%)                                              PFO (58; 18.2%)                                              **0.053**
                                                                                                                                       
  2          Valvular abnormalities (73; 19.1%)                           Valvular abnormalities (38; 11.9%)                           **0.014**
                                                                                                                                       
  3          Aortic calcification (73; 19.1%)                             Aortic calcification (32; 10.0%)                             **0.001**
                                                                                                                                       
  4          Aortic plaque (71; 18.5%)                                    Aortic plaque (31; 9.7%)                                     **0.002**
                                                                                                                                       
  5          Aoric valve aclerosis (45; 11.7%)                            Aoric valve aclerosis (21; 6.6%)                             **0.029**
                                                                                                                                       
  6          Atrial septal aneurysm (36; 9.4%)                            Left atrial dilatation (20; 6.3%)                            LA dilatation: 0.807
                                                                                                                                       
  7          regional myocardial dyskinesia in \> 2 segments (33; 8.6%)   regional myocardial dyskinesia in \> 2 segments (17; 5.3%)   0.131
                                                                                                                                       
  8          Left atrial dilatation (27; 7.0%)                            Atrial septal aneurysm (15; 4.7%)                            ASA 0.213
                                                                                                                                       
  9          ASD (17; 4.4%)                                               ASD (11; 3.4%)                                               0.65
                                                                                                                                       
  10         SEC(16; 4.2%)                                                Mitral valve prolapse (6; 1.9%)                              

In the older patients (\> 55 years, n = 291, according to \[[@B2],[@B10]\]) pathological echocardiographic findings were more frequent (p = 0.0023) than in the younger patients. The prevalence of a PFO was higher in the younger patients (\< 55 years: n = 78; 26.8%, \> 55 years: n = 75; 18.0%, Pearson\'s Chi square p = 0.005). The frequency of a ASD was lower in the older patients (\< 55 years: n = 28; 9.6%, \> 55 years: n = 20; 4.9%, Pearson\'s Chi square p = 0.014); see Figure [1](#F1){ref-type="fig"}, for examples see Figure [2](#F2){ref-type="fig"}, Figure [3](#F3){ref-type="fig"} and Figure [4](#F4){ref-type="fig"} and Additional file [1](#S1){ref-type="supplementary-material"}, Additional file [2](#S2){ref-type="supplementary-material"} and Additional file [3](#S3){ref-type="supplementary-material"}

![**Presence of PFO and ASD in the patients with cryptogenic stroke (n = 291 \< 55 years; n = 411 \> 55 years)**.](1476-7120-7-15-1){#F1}

![**TEE image showing a PFO with the clearly visible interatrial communication**.](1476-7120-7-15-2){#F2}

![**TEE showing the transfer of EchoVist from the right to the left atrium during Valsalva\'s manoeuvre**.](1476-7120-7-15-3){#F3}

![**TEE image showing an ASD and the color coded Dopper visualizing the left-to-right shunt**.](1476-7120-7-15-4){#F4}

The most frequent combination of two findings was PFO+ASA (2.63% male with IS, 2.71% male with TIA, 2.63% female with TIA, 2.71% female with IS).

Discussion
==========

This study is to our knowledge the largest TEE study in patients with cryptogenic cerebral ischemia allowing the analysis of the full spectrum of findings and especially the prevalence of a PFO.

In half of all patients, a possible cardiogenic cause was identified by TEE. The most frequent finding was a PFO. The frequency of positive TEE findings that might explain cerebral ischemia is comparable to previous smaller studies \[[@B11],[@B12]\].

Cardiogenic causes of ischemic stroke can be divided into major (annual incidence of embolic events \> 1%) and minor risk factors (annual incidence \< 1%) \[[@B13]\]. The major risk factors are atrial fibrillation (1--12%/year), intracardiac thrombi (0--35%), atrial myxoma (30--40%), mitral valve stenosis (8--14% in sinus rhythm, 31--65% with concomitant atrial fibrillation), recent myocardial infarction (1--2%), anticoagulated mechanical heart valves (1.5--3%), infective endocarditis (12--40%), dilated cardiomyopathy (4%) and aortic arch atheromatous plaques (4--16% especially if ≥ 4 mm in diameter, \[[@B14]\]). The minor risk factors include mitral valve prolapse (\<0.02%) and left ventricular aneurysm (\<1%). Rare causes of cardioembolism include Chiari network, Lambl\'s excrescences \[[@B15]\], and valvular abnormalities \[[@B16],[@B17]\]. Spontaneous echo contrast (SEC) is seen in areas of blood stasis with a slowly moving, cloud-like swirling pattern of \"smoke\" or increased echogenicity recorded in TEE. However, there is little data on the precise embolic risk of mitral valve annular calcification, spontaneous echo contrast, atrial septal aneurysm, and calcific aortic stenosis \[[@B13]\].

A substantial subset of the cardiogenic factors diagnosed by TEE could have been found with TTE (in combination with trans-cranial Doppler) as well. However, there are no prospective studies showing equivalent diagnostic accuracy of TTE compared to TEE in this setting. Despite the semi-invasivity of TEE, it is still the gold standard for the detection of inter-atrial communications.

TIA vs. stroke
--------------

Patients with TIA had less frequently a pathological finding in the TEE. This could be due to the fact that the initially suspected diagnosis \"TIA\" has a lower specificity with a broader range of other possible non-vascular etiologies such as migraine or focal seizures.

Age
---

We found a higher prevalence of PFO and ASD in the younger patients (\< 55 years). In contrast, Handke \[[@B10]\] reported that PFO are equally distributed in all age groups of patients with cryptogenic stroke. Despite these differences, relevant causes for cerebral ischemia can be identified in all age-groups. Therefore, a restriction of a TEE examination to younger patients with TIA/stroke is not supported by our data.

The current data does not allow a clear recommendation for PFO closure in patients with cryptogenic stroke. Further prospective studies are needed to decide on the clinical advantage of PFO closure, especially in patients \> 55 years of age.

Cardioembolic factors -- consequences
-------------------------------------

The TEE findings can have specific therapeutic consequences in all age groups (see table [4](#T4){ref-type="table"}). Specifically, as the therapeutic consequence of LA-appendage thrombus is oral anticoagulation, its presence should be ruled out before further treatment is limited to platelet aggregation inhibition alone \[[@B13],[@B18]\].

###### 

TEE findings in patients with ischemic stroke and their possible therapeutic consequences.

  **TEE finding**                  **Possible therapeutic consequence**
  -------------------------------- ------------------------------------------------------------------------
  PFO and ASD                      ASS, anticoagulation, operative or interventional device closure
                                   
  aortic plaques                   ASS, statin therapy
                                   
  reduced LVEF                     oral anticoagulation, ASS, coronary angiography, heart failure therapy
                                   
  left atrial dilatation           further cardiological work-up
                                   
  Spontaneous echo contrast        search for intermittent atrial fibrillation, oral anticoagulation
                                   
  left atrial thrombus             anticoagulation, operation
                                   
  thoracic aneurysm of the aorta   echo control, operation
                                   
  mitral valve prolapse            antiarrhythmic therapy, echo follow-up, anticoagulation
                                   
  aortic/mitral valve stenosis     timing of valve replacement
                                   
  LA-appendage thrombus            oral anticoagulation

PFO-ASA
-------

The association of ischemic stroke and PFO is still controversial: A recent large study in a multiethnic population did not confirm an association of PFO and the risk for an ischemic stroke \[[@B19]\]. However, two studies \[[@B20],[@B21]\]have seen a clear association of PFO and ASA in ischemic stroke.

The diagnosis of a PFO or ASA depends on experienced echocardiographers and has -- even among experienced examiners -- a high inter- and intra-observer variability \[[@B3]\]. Clear diagnostic criteria for intra-atrial defects could reduce the variability \[[@B9]\].

Surgical \[[@B22]\] or percutaneous closure of a PFO is a therapeutic strategy with somewhat inconsistent results \[[@B23],[@B24]\]. The percutaneous closure of a PFO after recurrent cerebral ischemia is a safe procedure and leads to a reduction of recurrence rates in the long-term follow-up. Only in a small number of patients, there was a residual shunt with subsequent TIA within the first six months after closure \[[@B25]\]. The recurrent ischemic events in these studies were attributed to a residual post-procedural shunt. Hence, improvement of occluder devices may further reduce the recurrence rates after PFO closure.

Conservative strategies (i.e. antithrombotic therapy) in patients with a PFO are also associated with comparable recurrence rates \[[@B26]\]. However, the risks of antithrombotic therapy (platelet inhibition, oral anticoagulation) include bleeding and low compliance rates. A randomized study (PICSS) did not reveal a significant difference in recurrence rates in medically treated patients with or without a PFO \[[@B4]\]. Especially in younger patients on medical therapy, the presence of a PFO did not increase the risk of stroke recurrence \[[@B27]\].

In addition to cardiogenic factors, recently, genetic polymorphisms of a variety of genes have been associated with cryptogenic stroke. However, the degree of association and the diagnostic relevance of these genetic polymorphisms is currently not clear \[[@B28]\].

On the background of our study, we recommend the following diagnostic algorithm for patients with cryptogenic stroke, which as applied in this study: clinical examination, electroencephalogram, cCT or cMRT, 12-lead-ECG, Holter-ECG, extracranial color-coded sonography, transcranial Doppler, transthoracic echocardiography. Only if these examinations do not reveal a cause for the stroke, a TEE seems indicated.

Conclusion
==========

In conclusion, in this large study in patients with cryptogenic stroke, a TEE reveals in about half of the patients cardiogenic factors that might explain the stroke. Especially, the prevalence of a PFO is higher in the younger patients (\< 55 years of age). Therefore, a TEE seems indicated in all patients with cryptogenic stroke -- irrespective of age -- because of specific therapeutic consequences.

Limitations
===========

This study was observational. The quality of observational studies seems to be comparable to randomized controlled trials \[[@B29],[@B30]\]. There was no follow-up of the patients concerning recurrence of cerebral ischemia or mortality.

We did not analyze the prevalence of abnormal TEE findings in single-vessel and lacunar strokes in comparison to multi-vessel strokes. The data of our study is historical (1996--2001). Currently, the indication for a TEE in cryptogenic stroke is more selective.
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TEE showing a PFO in 62°.
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###### Additional file 2

TEE showing inter-atrial transfer of EchoVist from the right atrium to the left atrium during Valsalva maneuver.
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###### Additional file 3

TEE showing a large ASD.
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